Home > Boards > US Listed > Miscellaneous > TherapeuticsMD, Inc. (TXMD)

Manipulation? I do not really think so.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
TechKim Member Profile
 
Followed By 84
Posts 26,197
Boards Moderated 0
Alias Born 09/15/03
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/10/2019 2:30:38 PM
TherapeuticsMD to Host Investor and Analyst Day Today Business Wire - 6/10/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/7/2019 7:16:23 AM
TherapeuticsMD & Theramex Enter into Exclusive License & Supply Agreement to Commercialize BIJUVA™ & IMVEXXY® Outside the ... Business Wire - 6/7/2019 7:15:00 AM
TherapeuticsMD to Host Investor and Analyst Day on June 10, 2019 in New York City Business Wire - 5/29/2019 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/15/2019 5:29:27 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/15/2019 7:03:21 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2019 6:01:29 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/8/2019 5:06:06 PM
TherapeuticsMD Announces Participation at the Bank of America Merrill Lynch 2019 Health Care Conference Business Wire - 5/8/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/6/2019 4:09:18 PM
TherapeuticsMD Announces First Quarter 2019 Financial Results Business Wire - 5/6/2019 4:05:00 PM
TherapeuticsMD Presented New Research at the American College of Obstetricians & Gynecologists 2019 Annual Meeting that Explo... Business Wire - 5/6/2019 7:00:00 AM
TherapeuticsMD Announces Oral & Poster Presentations on BIJUVA™ & ANNOVERA™ at the American College of Obstetricians & Gy... Business Wire - 5/3/2019 7:00:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/30/2019 6:21:37 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/30/2019 6:04:21 AM
TherapeuticsMD to Report First Quarter 2019 Results on May 6, 2019 Business Wire - 4/29/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/25/2019 4:36:00 PM
TherapeuticsMD Closes $300 Million Non-Dilutive Term Loan Financing Facility with TPG Sixth Street Partners Business Wire - 4/24/2019 4:10:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/17/2019 4:09:52 PM
TherapeuticsMD Signs Binding Commitment Letter for $300 Million Non-Dilutive Term Loan Financing Facility with TPG Sixth Stre... Business Wire - 4/17/2019 7:05:00 AM
TherapeuticsMD Announces Commercial Availability of BIJUVA™ in the U.S. Business Wire - 4/17/2019 7:00:00 AM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 4/10/2019 11:10:04 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/8/2019 7:02:02 AM
TherapeuticsMD Announces Oral and Poster Presentations on BIJUVA™ and ANNOVERA™ at the Endocrine Society 2019 Annual Meet... Business Wire - 3/25/2019 7:00:00 AM
TechKim   Tuesday, 11/07/17 06:06:11 PM
Re: JCB5 post# 375
Post # of 407 
Manipulation? I do not really think so. It rose near 60% the other day. What would you expect? Of course you could be totally correct, but some people just like taking a profit. Others glad to get their money back.

Opened at $6 and drifted lower by just 2.96% by the end of day. 2.96% manipulation? I would say anyone holding was darn lucky there was not more bottom today.

If does not make a worse case scenario from the FDA. I would expect a labeling penalty, along with a post marketing surveillance study (Phase 4). This makes sense.

One must remember that the FDA is responsible if they allow this drug to pass and something happens. It can go in any direction at the moment, regardless of what even the best opinions can give.

1/2 cent Vancouver penny mooching pirates!
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist